Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequences
- 28 February 1991
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 56 (2) , 181-185
- https://doi.org/10.1016/0304-3835(91)90094-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cisplatin stimulates the expression from the human immunodeficiency virus long terminal repeat sequences in human fibroblastsAnti-Cancer Drugs, 1990
- Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by cis-platinGene Analysis Techniques, 1990
- Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trialCancer, 1988
- The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIVCell, 1988
- Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cellsGene, 1988
- Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator proteinCell, 1987
- Promotor and enhancer like activity at the 5'‐end of normal and T24 Ha‐ras1 genesFEBS Letters, 1986
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeatCell, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Proliferation of buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA)Cell, 1977